Ftse Mib
34.659,72
-1,23%
DAX
20.087,19
-0,66%
S&P 500
5.827,04
-1,54%
NASDAQ
19.161,63
0,00%
Bitcoin
91.380,38
-3,27%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Labcorp Holdings Inc (LH) Labcorp Holdings Inc (LH) Notizie

Labcorp Holdings Inc

LH
232,00
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 13:00:09
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
10/1/202522:15PRNUSLabcorp to Speak at the 43rd Annual J.P. Morgan Healthcare..
09/1/202500:02PRNUSLABCORP DECLARES QUARTERLY DIVIDEND
08/1/202522:15PRNUSLabcorp to Announce Fourth Quarter Financial Results on..
17/12/202413:00PRNUSLabcorp Launches H5 Bird Flu Test in the U.S., Now Available..
04/12/202416:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202415:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/12/202422:15EDGAR2Form 144 - Report of proposed sale of securities
02/12/202421:36EDGAR2Form 144 - Report of proposed sale of securities
26/11/202417:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202414:05PRNUSOutcomes4Me and Labcorp Study Reveals Digital Education Can..
26/11/202413:52PRNUSOutcomes4Me and Labcorp Study Reveals Digital Education Can..
25/11/202414:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202422:56EDGAR2Form 144 - Report of proposed sale of securities
21/11/202421:20EDGAR2Form 144 - Report of proposed sale of securities
19/11/202413:13EDGAR2Form 8-K - Current report
19/11/202413:00PRNUSLabcorp CFO Glenn Eisenberg Announces Plans to Retire
13/11/202414:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/11/202414:44EDGAR2Form 144 - Report of proposed sale of securities
05/11/202414:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202414:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/11/202415:00BWPraia Health Secures Strategic Investment from Labcorp..
29/10/202416:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
25/10/202415:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/10/202422:21EDGAR2Form 144 - Report of proposed sale of securities
24/10/202412:58EDGAR2Form 8-K - Current report
24/10/202412:50PRNUSLabcorp Announces 2024 Third Quarter Results
16/10/202414:00BWNOWDiagnostics and Labcorp Collaborate to Expand Access to..
10/10/202414:30PRNUSLabcorp Expands Sexually Transmitted Infection (STI) Test..
10/10/202412:58EDGAR2Form 8-K - Current report
10/10/202412:50PRNUSLabcorp Declares Quarterly Dividend
24/9/202422:21EDGAR2Form 8-K - Current report
24/9/202422:16PRNUSLabcorp to Announce Third Quarter Financial Results on..
23/9/202422:18EDGAR2Form 8-K - Current report
18/9/202422:05EDGAR2Form 8-K - Current report
18/9/202413:00PRNUSOvia Health Expands Women's Health Offerings with..
18/9/202412:12EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/9/202400:35PRNUSLABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030,..
16/9/202423:30EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
16/9/202414:21EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/9/202413:30PRNUSLabcorp Completes Acquisition of Select Assets of..
03/9/202422:09PRNUSLabcorp to Speak at the Baird 2024 Global Healthcare..
09/8/202416:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/8/202413:00PRNUSLabcorp Finalizes Acquisition of Select Assets of Invitae
02/8/202414:30PRNUSLabcorp Receives FDA De Novo Marketing Authorization for..
01/8/202412:57PRNUSLabcorp Announces 2024 Second Quarter Results
30/7/202413:00PRNUSLabcorp Expands Collaboration with Ultima Genomics to..
25/7/202412:59PRNUSLabcorp Declares Quarterly Dividend
01/7/202413:00PRNUSLabcorp to Announce Second Quarter Financial Results on..
Apertura: Min: Max:
Chiusura: 232,00

La tua Cronologia

NYSE
LH
Labcorp
CSE
NC
NetCents Technology
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network